CiMaas and PharmaCell Enter a Collaborative Agreement
Maastricht, the Netherlands, July 13, 2015 / B3C newswire / -- CiMaas BV, a company developing cellular immunotherapy for cancer, and PharmaCell BV, a leading Contract Manufacturing Organization for Cellular Therapies and Regenerative Medicine in Europe, …